[News] Combination chemotherapy for adrenocortical carcinoma
23:55 EDT 14 Jun 2012 | The Lancet
A landmark study done in patients with advanced adrenocortical carcinoma confirms that the currently recommended combination chemotherapy (etoposide, doxorubicin, cisplatin, and mitotane: EDP/M) represents the best approach to treatment. “The EDP/M..
Original Article: [News] Combination chemotherapy for adrenocortical carcinoma
More From BioPortfolio on "[News] Combination chemotherapy for adrenocortical carcinoma"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
